Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 999.60
Bid: 998.40
Ask: 998.80
Change: -11.40 (-1.13%)
Spread: 0.40 (0.04%)
Open: 1,008.50
High: 1,010.00
Low: 994.80
Prev. Close: 1,011.00
SN. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

16 Nov 2022 11:30

RNS Number : 6398G
Smith & Nephew Plc
16 November 2022
 

SMITH & NEPHEW PLC

 

16 November 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

The following awards of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") vested on 14 November 2022, being the first business day post vesting date, under the Smith & Nephew Global Share Plan 2020.

 

i. PARTIAL VESTING OF CONDITIONAL SHARE AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 12 November 2021. One third of the Shares vested on 12 November 2022, a further third will vest on 12 November 2023 and the final third will vest on 12 November 2024. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting of a Conditional Share Award granted on 12 November 2021 under the Smith & Nephew Global Share Plan 2020.

Date of Transaction

2022 - 11 - 14

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Paul Connolly

(President, Global Operations)

PDMR

10.629361

10,290 (of which 2,992 were sold to cover taxes due and 7,298 retained)

N/A Single Transaction

7,298.00000 ordinary shares

 

0.00083%

 

Mizanu Kebede

(Chief Quality and Regulatory Affairs Officer)

PDMR

10.629361

5,049 (of which 1,621 were sold to cover taxes due and 3,428 retained)

N/A Single Transaction

4,139.84492 ordinary shares

(including 355.92246 in ADS')

 

 

0.00047%

 

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

2. VESTING OF A RESTRICTED STOCK UNIT AWARD GRANTED UNDER THE AWARD AGREEMENT DATED 29 APRIL 2022

 

In line with the announcement published on 3 May 2022, a Restricted Stock Unit Award of US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") granted to Deepak Nath vested on 13 November 2022. This Restricted Stock Unit Award formed part of the buy-out awards granted in respect of outstanding incentives Deepak Nath forfeited upon leaving his former company.

 

i. PARTIAL VESTING OF A RESTRICTED STOCK UNIT AWARD:

 

A Restricted Stock Unit Award of 14,364 shares was granted to Deepak Nath on 29 April 2022. One third of these shares (4,788 shares) vested on 13 November 2022, a further third will vest on 13 November 2023 and the final third will vest on 13 November 2024. A number of Shares were sold to cover taxation obligations arising on the vesting of the award.

 

The following relates to individual included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting of a Restricted Stock Unit Award granted on 29 April 2022 under the award agreement.

Date of Transaction

2022 - 11 - 14

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Total Ordinary Share Holding following the transaction *

Total Ordinary Share Holding as a % of the Company's ISC following the transaction *

Deepak Nath

(Chief Executive Officer)

Director

10.629361

4,788 (of which 1,170 were sold to cover taxes due and 3,618 retained)

N/A Single Transaction

9,189.00000 ordinary shares

0.00105%

 

 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVILTLRLIF
Date   Source Headline
18th Apr 20188:00 amRNSECC endorsed by Royal College of Surgeons
12th Apr 20184:12 pmRNSResult of AGM
9th Apr 20184:40 pmRNSDirector/PDMR Shareholding
4th Apr 20187:00 amRNSDirectorate Change
3rd Apr 20181:15 pmRNSTotal Voting Rights
12th Mar 201812:18 pmRNSDirector/PDMR Shareholding
8th Mar 20181:20 pmRNSDirector/PDMR Shareholding
8th Mar 20181:15 pmRNSDirector/PDMR Shareholding
6th Mar 20182:59 pmRNSTransaction in Own Shares
5th Mar 20184:30 pmRNSAnnual Financial Report
1st Mar 201812:29 pmRNSDirectorate Change
1st Mar 201810:54 amRNSTotal Voting Rights
27th Feb 20183:55 pmRNSDirector/PDMR Shareholding
15th Feb 20185:43 pmRNSTransaction in Own Shares
14th Feb 20186:10 pmRNSTransaction in Own Shares
13th Feb 20184:11 pmRNSDirector/PDMR Shareholding
12th Feb 20189:15 amRNSTransaction in Own Shares
9th Feb 201812:20 pmRNSDirector/PDMR Shareholding
8th Feb 20184:49 pmRNSDirector/PDMR Shareholding
8th Feb 20187:00 amRNSFinal Results
7th Feb 20189:33 amRNSSmith & Nephew announces European launch of PICO 7
2nd Feb 201810:31 amRNSBlock listing Interim Review
1st Feb 20181:40 pmRNSTotal Voting Rights
31st Jan 20189:06 amRNSAppointment of Roland Diggelmann as Non-Exec. Dir.
23rd Jan 201812:00 pmRNSSmith & Nephew update on tax
9th Jan 20184:34 pmRNSDirector/PDMR Shareholding
4th Jan 20184:03 pmRNSDirector Declaration
2nd Jan 20182:33 pmRNSTotal Voting Rights
6th Dec 20172:19 pmRNSSmith & Nephew pilot digital wound care solution
6th Dec 20177:00 amRNSAcquisition of Rotation Medical Inc
1st Dec 20173:09 pmRNSTotal Voting Rights
22nd Nov 201710:25 amRNSDirector/PDMR Shareholding
15th Nov 20173:29 pmRNSTransaction in Own Shares
15th Nov 20178:00 amRNSNew RCT demonstrates effectiveness of ALLEVYN LIFE
13th Nov 20175:00 pmRNSDirector/PDMR Shareholding
13th Nov 20171:00 pmRNSLaunch of robotics-assisted knee replacement
13th Nov 20179:55 amRNSDirector/PDMR Shareholding
8th Nov 20176:03 pmRNSTransaction in Own Shares
8th Nov 201710:31 amRNSDirector/PDMR Shareholding
7th Nov 20175:47 pmRNSTransaction in Own Shares
6th Nov 20172:10 pmRNSTransaction in Own Shares
3rd Nov 20177:00 amRNSTrading Statement
2nd Nov 201712:13 pmRNSDirector/PDMR Shareholding
1st Nov 20171:55 pmRNSTotal Voting Rights
1st Nov 20171:43 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:00 pmRNSAcquisition of tissue regeneration technology
19th Oct 201710:10 amRNSDividend Declaration
13th Oct 20179:00 amRNSNotice of Results
10th Oct 20174:21 pmRNSDirector/PDMR Shareholding
9th Oct 20177:00 amRNSRetirement of Chief Executive Officer by end 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.